Evidence map›Paper›PMID 31420699›Full record

ReviewDiabetologia2020

Cognitive dysfunction in diabetes: how to implement emerging guidelines.

Geert J Biessels, Rachel A Whitmer

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diabetologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 141 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed, 7 pooled it
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

141 citing papers in PubMed, 7 syntheses or guidelines pooled it, 290 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Review
  20. Article

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Geert J BiesselsDepartment of Neurology, G03.232, UMC Utrecht Brain Center, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, the Netherlands. g.j.biessels@umcutrecht.nl.ORCID 0000-0001-6862-2496
Rachel A WhitmerDepartment of Public Health Sciences, Division of Epidemiology, Population Brain Health Laboratory, University of California Davis, Davis, CA, USA.
University of California, Davis · USUtrecht University · NL

Funding

Predictors of Late-life Cognitive Health in Type 1 DiabetesR01AG047500 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI WHITMER, RACHEL A · 2015 to 2019
$3.0M
NIA NIH HHS R01 AG047500
6 · The paper itself

Abstract

Cognitive dysfunction, including mild cognitive impairment and dementia, is increasingly recognised as an important comorbidity and complication of diabetes that affects an individual's well-being and diabetes management, and is associated with diabetes treatment-related complications. Recent guidelines therefore recommend screening for cognitive impairment in older individuals with diabetes. In addition, these guidelines suggest that glucose-lowering treatment should be tailored in those diagnosed with cognitive impairment, to reduce the risk of hypoglycaemia and improve treatment adherence. This review gives an overview of cognitive dysfunction in people with diabetes, briefly describing the clinical features of different stages of cognitive dysfunction and their epidemiology. In particular, it addresses essential additional steps that need to be taken to fully implement the emerging guidelines on screening and management of cognitive dysfunction in diabetes into daily practice.

Indexed as

Alzheimer DiseaseCognition DisordersCognitive DysfunctionDiabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2FemaleHumansMaleAlzheimer’s diseaseCognitive dysfunctionDementiaGuidelinesImplementationMild cognitive impairmentReviewScreeningType 1 diabetesType 2 diabetes

Identifiers

PMID31420699
PMCPMC6890615
OpenAlexW2968585277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.